Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Imagine this: You walk into your doctor and get your yearly flu vaccine and a yearly dose of your weight-loss injection. If Eli Lilly has its way, this may be the future of obesity care.

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

Pharmacy leaders have issued a fresh warning over ... drugs such as Wegovy or Mounjaro. A person’s medical history should also be examined before sellers decide whether or not to dispense a ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Pharmacy leaders have issued a warning over the online ... questionnaires to access drugs such as Wegovy or Mounjaro. A person's medical history should also be examined before sellers decide whether ...

Pharmacy leaders have issued a fresh warning over ... drugs such as Wegovy or Mounjaro. A person’s medical history should also be examined before sellers decide whether or not to dispense a ...

A new weight-loss drug policy? The latest class of weight-loss drugs - also known as GLP-1 agonists - are "the most potent w ...

Patrik Jonsson is an executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health.Courtesy Eli Lilly; Getty Images; BI Illustration Eli Lilly makes the popular shots ...